Response to antiviral therapy for chronic hepatitis C and risk of hepatocellular carcinoma occurrence in Japan: a systematic review and meta-analysis of observational studies
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Response to antiviral therapy for chronic hepatitis C and risk of hepatocellular carcinoma occurrence in Japan: a systematic review and meta-analysis of observational studies
Authors
Keywords
-
Journal
Scientific Reports
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-03-01
DOI
10.1038/s41598-023-30467-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The impact of unrestricted access to direct-acting antiviral among incarcerated hepatitis C virus-infected patients
- (2021) Yu Jun WONG et al. Clinical and Molecular Hepatology
- Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside
- (2021) Don C. Rockey et al. GASTROENTEROLOGY
- Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosis
- (2021) Chen-Hua Liu et al. Clinical and Molecular Hepatology
- A cost-effectiveness study of universal screening for hepatitis C virus infection in South Korea: A societal perspective
- (2021) Hye-Lin Kim et al. Clinical and Molecular Hepatology
- Cost-effectiveness of chronic hepatitis C screening and treatment
- (2021) Hye Won Lee et al. Clinical and Molecular Hepatology
- Scaling up the in-hospital hepatitis C virus care cascade in Taiwan
- (2020) Chung-Feng Huang et al. Clinical and Molecular Hepatology
- Hepatocellular carcinoma occurrence does not differ between interferon‐based and interferon‐free treatment with liver histological assessment
- (2019) Yuki Tahata et al. HEPATOLOGY RESEARCH
- Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis
- (2019) Catherine de Martel et al. Lancet Global Health
- Meta-regression Analysis of Sex- and Birth Year-Specific Prevalence of HBsAg and Anti-HCV Among Un-diagnosed Japanese: Data From the First-time Blood Donors, Periodical Health Checkup, and the Comprehensive Health Checkup With Lifestyle Education (Ningen Dock)
- (2019) Tomoyuki Akita et al. JOURNAL OF EPIDEMIOLOGY
- The short-term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct-acting antivirals: An ERCHIVES study
- (2018) Darrick K. Li et al. HEPATOLOGY
- Effect of interferon-based and -free therapy on early occurrence and recurrence of hepatocellular carcinoma in chronic hepatitis C
- (2017) Hiroko Nagata et al. JOURNAL OF HEPATOLOGY
- The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy
- (2017) Yuko Nagaoki et al. PLoS One
- Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
- (2016) María Reig et al. JOURNAL OF HEPATOLOGY
- Sustained virologic response by direct antiviral agents reduces the incidence of hepatocellular carcinoma in patients with HCV infection
- (2016) Masahiro Kobayashi et al. JOURNAL OF MEDICAL VIROLOGY
- Viral eradication reduces all-cause mortality in patients with chronic hepatitis C virus infection: a propensity score analysis
- (2016) Toshifumi Tada et al. LIVER INTERNATIONAL
- Impact of hepatitis C virus eradication on hepatocellular carcinogenesis
- (2015) Darrick K. Li et al. CANCER
- World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma
- (2015) Catherine de Martel et al. HEPATOLOGY
- Effect of peginterferon alfa-2b and ribavirin on hepatocellular carcinoma prevention in older patients with chronic hepatitis C
- (2015) Takashi Honda et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Changes in hepatitis C virus genotype distribution in Japan
- (2014) H. TOYODA et al. EPIDEMIOLOGY AND INFECTION
- Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma
- (2013) Rebecca L. Morgan et al. ANNALS OF INTERNAL MEDICINE
- Post-treatment Levels of α-Fetoprotein Predict Incidence of Hepatocellular Carcinoma After Interferon Therapy
- (2013) Tsugiko Oze et al. Clinical Gastroenterology and Hepatology
- Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C
- (2012) Yasuji Arase et al. HEPATOLOGY
- Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: A prospective, multicenter study
- (2012) Eiichi Ogawa et al. JOURNAL OF HEPATOLOGY
- Pharmacology and therapeutic potential of interferons
- (2012) Peter M. George et al. PHARMACOLOGY & THERAPEUTICS
- Cancer preventive effect of pegylated interferon α-2b plus ribavirin in a real-life clinical setting in Japan: PERFECT interim analysis
- (2011) Sumio Watanabe et al. HEPATOLOGY RESEARCH
- Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis C
- (2011) Hirokazu Takahashi et al. JOURNAL OF GASTROENTEROLOGY
- Decrease in alpha-fetoprotein levels predicts reduced incidence of hepatocellular carcinoma in patients with hepatitis C virus infection receiving interferon therapy: a single center study
- (2011) Yukio Osaki et al. JOURNAL OF GASTROENTEROLOGY
- Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study
- (2010) Andri Rauch et al. GASTROENTEROLOGY
- Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection
- (2010) Yasuhiro Asahina et al. HEPATOLOGY
- λ-Interferons and the single nucleotide polymorphisms: A milestone to tailor-made therapy for chronic hepatitis C
- (2010) Yasuhito Tanaka et al. HEPATOLOGY RESEARCH
- Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors
- (2010) Masayuki Kurosaki et al. JOURNAL OF HEPATOLOGY
- Randomized Study of Peginterferon-α2a Plus Ribavirin vs Peginterferon-α2b Plus Ribavirin in Chronic Hepatitis C
- (2009) Maria Grazia Rumi et al. GASTROENTEROLOGY
- Effect of interferon α-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis
- (2009) Mika Kurokawa et al. HEPATOLOGY RESEARCH
- Prevention of hepatocellular carcinoma complicating chronic hepatitis C
- (2009) Yoshiyuki Ueno et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
- (2009) Dongliang Ge et al. NATURE
- Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
- (2009) David L. Thomas et al. NATURE
- IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
- (2009) Vijayaprakash Suppiah et al. NATURE GENETICS
- Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
- (2009) Yasuhito Tanaka et al. NATURE GENETICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started